The Efficacy of Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Assiut University
- Enrollment
- 50
- Primary Endpoint
- increase in the addiction severity index for methamphetamine use disorder
Study Overview
Brief Summary
The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder
Detailed Description
Methamphetamine (MA) use is a serious public health concern in many countries and is second to cannabis as the most widely abused illicit drug in the world.
Over the past few years; there is an alarming increase in crystal methamphetamine (Shabu) abuse in the Egyptian market and The Egyptian government is annoyed from this issue because youth within the age of productivity were targeted.
Regular methamphetamine use can be associated with a range of psychiatric symptoms, particularly psychosis, anxiety, and depression.
No FDA approved pharmacological treatments are available for Meth addiction up till now and despite great advances achieved in understanding the neurobiology of drug addiction, the therapeutic options are severely limited . Consequently, the only available treatment at present is psychosocial intervention.
The effectiveness of CBT for other substance-use disorders (e.g. alcohol-, opioid- and cocaine-use disorders) has been well documented and as such this basic treatment approach has been applied to amphetamine-type stimulant (ATS)-use disorder .
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 15 Years to 50 Years (Child, Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients who meet the criteria for methamphetamine use disorder according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5) (10)
- •aged of 15-49 years' old
- •more than 9 year of education
- •urine drug screening positive for methamphetamine
Exclusion Criteria
- •other Axis I disorder of DSM-V criteria such as bipolar disorder, schizophrenia, depression
- •Had a legal case pending resulting in inability to commit to 12 weeks of treatment.
- •Refusal to participate
- •poly drug dependence.
Outcomes
Primary Outcomes
increase in the addiction severity index for methamphetamine use disorder
Time Frame: 12 weeks
0-1 No imminent problem 2-3 slight problem 4-5 moderate problem 6-7considerable difficulty
Secondary Outcomes
No secondary outcomes reported
Investigators
Ahmad Tharwat Ahmad
Assistant lecture
Assiut University